Is NVIDIA Stock’s New CPU Story Big Enough to Cover Its China Silence?

As management pivots hard to a massive new market, they’ve stopped detailing the multi-billion-dollar hole left by China, a quiet shift investors can’t afford to ignore as growth slows.

With NVIDIA (NVDA) stock delivering a stunning 70.7% revenue surge over the last year, it’s easy to get swept up in the triumphant narrative. Management is now busy “rebuilding computing for agentic AI” and opening up what it calls a “brand new $200 billion TAM” with its new Vera CPU. But amid the celebration, a once-critical topic has gone quiet. The question for any holder is whether the new story is simply the next chapter or if it’s also a necessary replacement for a growth engine that was permanently shut down.

The silence that has settled over its China business is what’s worth noticing.

The Multi-Billion Dollar Problem That Vanished

It wasn’t long ago that navigating U.S. export controls was a central theme. Management was upfront about the financial hit, specifically from its custom H20 chip. Just a few quarters ago, an executive noted the direct impact, stating, “We were unable to ship $2.5 billion in H20 revenue in the first quarter.” That figure, a multi-billion-dollar quarterly headwind, was a recurring topic, complete with discussions of a “multibillion-dollar write-off on inventory.” It was a real, quantified problem they were actively managing.

Now, you hear far less about it. The focus has decisively shifted. In the latest call, the company’s position was starkly different: “we are not including any China data center compute revenue in our outlook.” The problem hasn’t been solved so much as it has been surgically removed from the forward-looking story.

From GPU Headwind To CPU Tailwind

In its place is a bold new narrative. The company is now aiming to become the “world-leading CPU supplier.” This isn’t a minor product line extension; it’s a frontal assault on a new market. Management has put a hard number on this ambition, forecasting “visibility to nearly $20 billion in total CPU revenue this year.” The story has pivoted from managing a geopolitical constraint on its core GPU business to launching a massive new growth engine in CPUs.

The sheer scale of the new story is designed to command attention. But the timing of this pivot is what makes the silence on China so significant. It coincides with a material change in the company’s growth trajectory. While still incredibly high, NVIDIA’s 70.7% year-over-year revenue growth represents a clear deceleration from its 121.7% three-year average.

Why This Silence Is Concerning

This is where the silence becomes a signal. The quiet disappearance of the China headwind from the narrative doesn’t mean the revenue hole disappeared with it. It means the new CPU story now has to work much harder. It must not only create its own growth but also backfill the permanent loss of a major market, all while the core business comes off its peak acceleration.

The verdict here leans toward concerning, not because the company is in trouble, but because of the increased dependency on a single, new, and still-unproven initiative. The Vera CPU is no longer just an exciting opportunity; it’s a strategic necessity to keep the hyper-growth narrative alive.

For investors, the takeaway is simple: the new CPU business must deliver on its massive promise. The key thing to watch on the next earnings call is any update on that “nearly $20 billion” CPU revenue figure. If it materializes as guided, the China silence will look like a footnote to a brilliant pivot. If it falters, that silence will start to feel a lot louder.

What To Check Before The Next Print

Do not take the new story on faith. Open the segment breakdown and confirm the engine management stopped talking about is still pulling its weight. Healthy and quiet is fine. Quiet and slowing is the combination worth fearing, and the next call is where you will see which one it is. Want this distilled into an actual buy list rather than a watch item? The Trefis High Quality Portfolio tracks fundamental signals across 30 stocks with rules-based re-balancing, and has beaten the S&P 500, S&P Mid-cap, and Russell 2000 with cumulative returns of over 105% since inception.